What's The BUZZ?

Market News, Products, Services, and Trends

Advertisement
Banner Ad Advertisement

Responding to Change in the Pharmaceutical Compounding Industry

Responding to Change in the Pharmaceutical Compounding Industry

A lot has happened in the world of sterile, compounded medicine in the past decade – from the creation of sections 503A and 503B in the Federal Food, Drug, and Cosmetic Act, to the complete overhaul of the USP <797> standards used to manufacture and test products. The role of a compounding pharmacist has expanded. Compounders must navigate how to create products with tighter oversight and shorter shelf-life. To do so, compounding pharmacists must become supply chain, manufacturing, and Quality Control experts. Read More >

Charles River

Charles River News & Announcements

In today’s world, quality and compliance are non-negotiable, and yesterday’s standards are no longer sufficient to meet the demands of a constantly evolving landscape. The field of quality control microbiology is undergoing a disruptive revolution to safeguard patient safety, evolving beyond traditional methods to optimize resources, minimize human error, enable sustainable alternatives, and maintain consistent quality standards. Every test, every result, and every data point define the success of life-changing therapies. That’s why we’re leading a new paradigm, one that redefines efficiency, sustainability, and innovation. Let’s rethink the future of microbial quality control, where modern, automated, data-centric, and scalable solutions are the norm, empowering you to stay ahead in a dynamic regulatory and operational landscape.  Together, we are not just preparing for the future. We’re rethinking it. Because every moment matters.

RXinsider Staff

Posted by: RXinsider Staff

RXinsider is a multimedia publishing and technology company offering print publications, digital platforms, events, and content creation services to the B2B pharmacy market.

SUBSCRIBE

Name
Subscription Choices
Checkboxes

Request information from Responding to Change in the Pharmaceutical Compounding Industry

Name
Address
Subscribe